Abstract:Background: While thousands of patients undergo stress testing annually, the risk of exercise and pharmacologic stress in patients with carotid artery disease has not been fully defined but is of concern as patients are at risk for cerebrovascular accidents and transient ischemic attacks. Methods: All patients with either ultrasound or CTA evaluation of their carotid arteries from over a 10 year period who underwent stress testing within 180 days without intervening carotid intervention were reviewed for any adverse events within 24 hours of their stress test. The primary end point was any cerebrovascular event or syncope while the secondary endpoints included death, myocardial infarction, urgent angiography, urgent revascularization, or exaggerated hemodynamic response (systolic BP drop > 20 mmHg or systolic BP > 180 mmHg at peak stress). Patients were stratified into categories based on their level of carotid disease. Patients with severe carotid stenosis were propensity matched to those with mild or no stenosis. Results: A total of 4457 patients underwent carotid ultrasound, 10,644 CTA, and 16,011 had stress testing during this time period with 514 having both a carotid evaluation and a stress test within 6 months. After propensity matching, 62 patients with severe carotid stenosis were matched to 170 patients with mild or no carotid stenosis. Incidentally, all patients with severe carotid stenosis underwent pharmacologic stress. There were no primary endpoints and only three secondary endpoints in two patients in the mild or no carotid stenosis group. The proportion of exaggerated hemodynamic response to stress was similar in both groups-21.0% in the carotid stenosis group vs 31.2% without (P = .17) having a significant drop in systolic BP, and 3.2% vs 4.7% (P = 1.0) having a significantly elevated systolic BP. Conclusion: In this study cohort there were few primary and secondary outcome events with no events occurring in patients with significant carotid stenosis. Additionally, there was no difference in exaggerated hemodynamic responses. While these results suggest that stress testing entails no demonstrable increased risk in patients with significant carotid stenosis, continued care should be taken given the limitations of the small size of this study.

'Template-switching': a supramolecular strategy for the quantitative, gram-scale construction of a molecular target in the solid state.

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR

Adenosine vs. regadenoson for stress induction in dynamic CT perfusion scan of the myocardium: A single‑center retrospective comparison

Complete Genome Sequence of Brucella suis VBI22, Isolated from Bovine Milk

Abstract 16817: Comparison of Diagnostic Performance of Quantitative Perfusion Stress Myocardial Perfusion Imaging With Cardiac Magnetic Resonance Between Different Vasodilators

A Comparative Study of Dipyridamole and Acetazolamide in Stress Cerebral Perfusion Imaging

Adenosine and a Selective A2a Receptor Agonist Regadenoson Used in Myocardial Stress Test

Incidence of reversible defect seen on myocardial perfusion scintigraphy using dipyridamole pharmacologic test early after primary percutaneous coronary intervention: how safe is it to perform this protocol?

The prognostic utility of heart rate and blood pressure response to regadenoson stress

Prognostic value of myocardial perfusion imaging by cadmium zinc telluride single-photon emission computed tomography in patients with suspected or known coronary artery disease: a systematic review and meta-analysis

Smart grid in Japan associated with lightning protection of renewable energies

The safety of carotid stenosis during vasodilator pharmacologic stress testing

Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery Disease

10-year experience of utilizing a stress-first SPECT myocardial perfusion imaging

Splenic switch-off in regadenoson 82Rb-PET myocardial perfusion imaging: assessment of clinical utility

Comparing a high-dose dipyridamole SPECT imaging protocol with dobutamine and exercise stress testing protocols. Part II: Using high-dose dipyridamole to determine lung-to-heart ratios

Safety of Adenosine in Stress Cerebral Perfusion Imaging

Clinical and economic outcomes of pharmacological stress tests in patients with a history of COVID-19

Re: "Bonsai-like appearance": a unique feature of multicentric hepatoma.

Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls

Head-to-head comparison of diagnostic accuracy of stress-only myocardial perfusion imaging with conventional and cadmium-zinc telluride single-photon emission computed tomography in women with suspected coronary artery disease